Publications by authors named "Simon Arnett"

Claim this Profile
T
Treatment outcomes in multiple sclerosis using reduced and extended interval ocrelizumab dosing.
Antonia McLean, Simon Arnett, Joshua Yap, Sin Hong Chew, Ping Zhang

Mult Scler Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.
Claudia Chien, Vera Cruz E Silva, Emanuel Geiter, Dominik Meier, Hanna Zimmermann, Simon Arnett

Radiology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis.
Simon V Arnett, Kerri Prain, Sudarshini Ramanathan, Sandeep Bhuta, Fabienne Brilot

J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Simon Arnett, Sin Hong Chew, Unnah Leitner, Jyh Yung Hor, Friedemann Paul

J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis.
Simon Arnett, Sofia Jimenez Sanchez, Jennifer Downing, Mike Boggild, Jing Sun

Mult Scler Relat Disord· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to treatment in NMOSD: the Australasian experience.
Laura Clarke, Wajih Bukhari, Cullen M O'Gorman, Elham Khalilidehkordi, Simon Arnett, Michael H Barnett

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Laura Clarke, Simon Arnett, Kate Lilley, Jacky Liao, Sandeep Bhuta

Clin Exp Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Laura Clarke, Simon Arnett, Wajih Bukhari, Elham Khalilidehkordi, Sofia Jimenez Sanchez, Michael H Barnett

Front Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, Wajih Bukhari, Sofia Jimenez Sanchez, Michael H Barnett

Front Neurol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical profile of NMOSD in Australia and New Zealand.
Wajih Bukhari, Laura Clarke, Cullen O'Gorman, Elham Khalilidehkordi, Simon Arnett, Michael H Barnett

J Neurol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis